Nanhu Brain-Computer Interface Cross-Disciplinary Research Institute Says Technology Is at Clinical Trial Stage, Report Says

leaderobot.com reported on the state of brain-computer interfaces in connection with the Nanhu Brain-Computer Interface Cross-Disciplinary Research Institute on September 26, 2026. The article says Duan Shumin stated that the technology remains at the clinical trial stage.

Describing brain-computer interfaces as being at the “clinical trial stage” indicates that research results do not automatically become products for ordinary patients. This should be understood as the current assessment offered by the announcing party; the focus will be on whether the technology can meet clinical, regulatory and insurance requirements.

The article provides an example of discussion about brain-computer interfaces shifting from introducing research to assessing how close the technology is to clinical implementation. However, the original source is an interview, not a primary source detailing the Nanhu Brain-Computer Interface Cross-Disciplinary Research Institute’s specific device specifications, target patients or approval status. Readers should consult the original source for details. There is no publicly supplied information about related articles from this newspaper to connect with past coverage, so external past articles cannot be added. In the broader public record, issues differ between invasive and noninvasive brain-computer interfaces: for the former, decoding accuracy and clinical application have been central; for the latter, the focus has been on noninvasiveness and broader use. Viewed in this context, Duan’s remarks suggest that the key to adoption is shifting from whether the technology works to who can use it, under what conditions and to what extent it can be standardized. The mention of the Nanhu Brain-Computer Interface Cross-Disciplinary Research Institute brings the discussion from research in general to a specific implementation body conducting clinical trials. The important point is that a brain-computer interface is not just a standalone measurement technology, but a medical system combining electrodes, signal processing, patient selection and rehabilitation design. Thus, describing it as being at the clinical trial stage implies evaluation not only of performance but also of reproducibility, long-term stability and regulatory compliance. At the same time, the original source does not make clear which approach the Nanhu Brain-Computer Interface Cross-Disciplinary Research Institute is prioritizing, which conditions it is targeting or how far development toward practical use has progressed. Points to check going forward include whether it is focusing on invasive or noninvasive approaches, the diseases and number of cases covered by its clinical trials, and whether approval, mass production or insurance coverage is the next hurdle.